Latest Form 4 insider transactions

Aaron M. Kale, Chief Accounting Officer of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Darcy Antonellis, a Director of Cinemark Holdings, Inc., received 5,439 shares of common stock on June 15, 2026.

Lindsay J. Radkoski, CMO, U.S. of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Alternative Credit Income Fund has filed a Rule 425 document detailing the launch of a new investment fund, outlining its structure and objectives.

Assaf Feldman, Chief Strategy Officer - Tech, a Director and 10% owner of Riskified Ltd., sold 656,096 shares of common stock on August 12, 2026.

Matthew P Spessard, Chief Information Officer of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Mark A Esquivel, President & COO of Park Aerospace Corp, sold 40,000 shares of common stock on August 13, 2026 for $37.00 per share.

Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc., sold 16,142 shares of common stock on August 13, 2026 for $27.61 per share.

Michael Nofi, Chief Financial Officer of Edgewise Therapeutics, Inc., reported multiple transactions in common stock on August 12, 2026.

Jennifer Larson, Chief Financial Officer of Bicara Therapeutics Inc., received 285,000 shares of common stock on August 12, 2026.

LivePerson provides detailed instructions for employee shareholders to vote on the proposed merger with SoundHound AI, emphasizing the importance of every vote.

Bryan Lee Stovall, COO - Metal Coatings of Azz Inc, sold 2,677 shares of common stock on August 14, 2026 for $150.07 per share.

Joanne M. Donovan, CMO of Edgewise Therapeutics, Inc., sold 9,441 shares of common stock on August 12, 2026.

Alan J Russell, Chief Scientific Officer and a Director of Edgewise Therapeutics, Inc., sold 5,901 shares of common stock on August 12, 2026.

John R Moore, General Counsel of Edgewise Therapeutics, Inc., sold 5,016 shares of common stock on August 12, 2026.

Behrad Derakhshan, Chief Business Officer of Edgewise Therapeutics, Inc., sold 5,100 shares of common stock on August 12, 2026.

Fazal F Merchant, a Director of Warner Bros. Discovery, Inc., sold 71,539 shares of common stock on August 13, 2026 for $27.75 per share.

John Min, Chief Legal Ofcr & Secretary of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Kevin Koch, President and CEO and a Director of Edgewise Therapeutics, Inc., sold 17,971 shares of common stock on August 12, 2026.

Ban Seng Teh, EVP & Chief Commercial Officer of Seagate Technology Holdings plc, sold 7,361 shares of common stock on August 13, 2026.

Peter J. Suerken Jr, President, U.S. of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Brian E Shore, Board Chairman & CEO and a Director of Park Aerospace Corp, sold 15,000 shares of common stock on August 12, 2026.

Richard W Fisher, a Director of Warner Bros. Discovery, Inc., sold 20,000 shares of common stock on August 12, 2026 for $27.46 per share.

Dafna Sarnoff, Chief Marketing Officer of CarGurus, Inc., sold 17,151 shares of common stock on August 13, 2026 for $37.00 per share.

Greg M Schwartz, a Director of CarGurus, Inc., sold 10,000 shares of common stock on August 12, 2026 for $36.07 per share.

Ryan J. Watts, President and CEO and a Director of Denali Therapeutics Inc., reported a transaction in 32,220 shares of common stock on August 12, 2026.

Nth Cycle, a critical mineral refining company, is set to combine with Kensington Capital Acquisition Corp. VI, aiming to build the West's refining capacity for essential minerals.

James L L Tullis, a Director of Crane Co, sold 614 shares of common stock on August 13, 2026 for $225.00 per share.

Randy J Taylor, See Remarks of US Foods Holding Corp., sold 11,630 shares of common stock on August 13, 2026.

Kevin Mark Wilson, Chief Executive Officer of Verb Technology Company, Inc., purchased 7,300 shares of common stock on August 13, 2026.